OT

Olabisi T. Ojo

Department of Radiation Oncology, University of Ibadan/University College Hospital, Ibadan.

3 Publications

Publications 3

1
Research Article Vol. 2, Issue 1

COMPARATIVE OUTCOMES OF RADIATION TREATMENT MODALITIES FOR PROSTATE CANCER IN A RESOURCE-LIMITED SETTING

Adebayo A Oladeji, Ayorinde M. Folasire*, Foluke O. Sarimiye, Chiamaka G. Ehiedu, Olabisi T. Ojo

Background: Prostate cancer remains a major malignancy in sub-Saharan Africa, where access to advanced radiotherapy is limited. Objective: This study compares biochemical recurrence-free survival (bRFS) and toxicity outcomes among prostate cancer patients who received external beam radiotherapy (EBRT) alone, high-dose-rate brachytherapy (HDRBT) mon...

Feb, 2026 Vol. 2, Issue 1
PDF
2
Research Article Vol. 1, Issue 2

EFFECTS OF BRACHYTHERAPY BOOST ON PROSTATE CANCER TREATED WITH EXTERNAL BEAM RADIOTHERAPY: A PILOT STUDY

Abbas A. Abdus-salam*, Olabisi T. Ojo, Chiamaka G. Ehiedu, Maryam A. Bashir, Atara I. Ntekim, Adewunmi O. Alabi, Sharif A. Folorunso, Mutiu A. Jimoh, Foluke O. Sarimiye, Adeniyi A Adenipekun

Background: Prostate cancer is the leading cause of cancer amongst men in Nigeria. External beam radiotherapy (EBRT) and high-dose rate brachytherapy (HDR-BT) play a significant role in the management of localised prostate cancer.Objective: This study compared the treatment outcome of the management of intermediate and high-risk localised prostate ...

Jul, 2025 Vol. 1, Issue 2
PDF
3
Research Article Vol. 1, Issue 2

A PROGRESSIVE EMBRYONAL RHABDOMYOSARCOMA OF THE UTERINE CERVIX WITH RIGHT BREAST LUMP IN A 43-YEAR-OLD ADULT: A CASE REPORT

Amina I Dansani*, Tajudeen A. Olasinde, Olabisi T. Ojo, Aisha Mustapha, Shehu Abdullahi, Shehu S. Umar

Introduction: Embryonal Rhabdomyosarcoma is an uncommon type of sarcoma often seen in pediatric and adolescent patients, with the botryoid subtype being the most common. The incidence of this disease in adult females is 0.4% to 1% with the affected age group being patients in the third to fourth decade of life. It is rare in patients above 40 years...

Jul, 2025 Vol. 1, Issue 2
PDF
Back to Articles